Stocks · Health care · Pharmaceutical Preparations

Evolus, Inc.

EOLS Clue Score45
United States Fiscal year ends December CIK 0001570562 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David Moatazedi
20 Mar 2026
See Remarks
Sold on a plan
13,669
$4.75
$64.93K
Rui Avelar
17 Mar 2026
See Remarks
Sold on a plan
29,996
$4.89
$146.63K
David Moatazedi
17 Mar 2026
See Remarks
Sold on a plan
116,720
$4.89
$570.56K
Rui Avelar
22 Dec 2025
See Remarks
Sold on a plan
2,261
$7.15
$16.17K
David Moatazedi
22 Dec 2025
See Remarks
Sold on a plan
10,539
$7.15
$75.36K

What was left out

Form 4 filings counted 15
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 5
Sales straight out of an exercise 0
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 833,702
History held since 13 Feb 2018